company background image
DP3 logo

Central Pharmaceutical No3 HNX:DP3 Stock Report

Last Price

₫58.00k

Market Cap

₫1.2t

7D

0%

1Y

-10.8%

Updated

25 Dec, 2024

Data

Company Financials

Central Pharmaceutical Joint Stock Company No3

HNX:DP3 Stock Report

Market Cap: ₫1.2t

DP3 Stock Overview

Engages in the manufacturing and sale of pharmaceutical products primarily in Vietnam and internationally. More details

DP3 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance5/6
Financial Health6/6
Dividends3/6

My Notes

Capture your thoughts, links and company narrative

Central Pharmaceutical Joint Stock Company No3 Competitors

Price History & Performance

Summary of share price highs, lows and changes for Central Pharmaceutical No3
Historical stock prices
Current Share Price₫58,000.00
52 Week High₫77,000.00
52 Week Low₫57,500.00
Beta0.36
1 Month Change0.52%
3 Month Change-7.64%
1 Year Change-10.77%
3 Year Change28.32%
5 Year Change95.95%
Change since IPO590.48%

Recent News & Updates

Recent updates

Shareholder Returns

DP3VN PharmaceuticalsVN Market
7D0%1.1%-0.03%
1Y-10.8%33.8%10.5%

Return vs Industry: DP3 underperformed the VN Pharmaceuticals industry which returned 33.8% over the past year.

Return vs Market: DP3 underperformed the VN Market which returned 10.5% over the past year.

Price Volatility

Is DP3's price volatile compared to industry and market?
DP3 volatility
DP3 Average Weekly Movement2.0%
Pharmaceuticals Industry Average Movement3.6%
Market Average Movement3.6%
10% most volatile stocks in VN Market6.8%
10% least volatile stocks in VN Market2.0%

Stable Share Price: DP3 has not had significant price volatility in the past 3 months compared to the VN market.

Volatility Over Time: DP3's weekly volatility (2%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1962n/an/awww.duocphamtw3.com

Central Pharmaceutical Joint Stock Company No3 engages in the manufacturing and sale of pharmaceutical products primarily in Vietnam and internationally. The company offers medicines from medicinal herbs; pharmaceutical drugs; food that protects health products; and medical equipment; as well as cosmetics products. It is involved in the production and testing of drugs; growing spices and medicinal plants; production of functional foods; distilling and blending of spirits; production of non-alcoholic beverages and mineral water; and manufacturing of soaps, detergents, polishes, and toilet preparations.

Central Pharmaceutical Joint Stock Company No3 Fundamentals Summary

How do Central Pharmaceutical No3's earnings and revenue compare to its market cap?
DP3 fundamental statistics
Market cap₫1.24t
Earnings (TTM)₫119.19b
Revenue (TTM)₫395.21b

10.5x

P/E Ratio

3.2x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
DP3 income statement (TTM)
Revenue₫395.21b
Cost of Revenue₫126.63b
Gross Profit₫268.58b
Other Expenses₫149.39b
Earnings₫119.19b

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)5.54k
Gross Margin67.96%
Net Profit Margin30.16%
Debt/Equity Ratio0%

How did DP3 perform over the long term?

See historical performance and comparison

Dividends

5.2%

Current Dividend Yield

51%

Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/25 16:40
End of Day Share Price 2024/12/25 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Central Pharmaceutical Joint Stock Company No3 is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution